Trials / Conditions / Measurable Residual Disease
Measurable Residual Disease
3 registered clinical trials studyying Measurable Residual Disease — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Motixafortide for MRD Sensitization in AML NCT07392970 | Washington University School of Medicine | Phase 2 |
| Recruiting | Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer NCT06595966 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Completed | MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of NCT06000306 | Zhejiang University | — |